Stocks TelegraphStocks Telegraph
Stock Ideas

LXRX Stock Performance and Key Statistics

NASDAQ : LXRX

Lexicon Pharmaceuticals

$1.63
0.02+1.24%
Open: 4:00 PM
73.08
BESG ScoreESG Rating

stock performance chart

LXRX Fundamental Analysis

Based on recent data, Lexicon Pharmaceuticals, Inc. (LXRX) shows an Average True Range (ATR) of 0.12 and an Enterprise Value of 477.58M. Its average trading volume over the past 3 months is 2.36M, indicating liquidity. These fundamental metrics provide insight into LXRX's underlying financial health and market activity.

ATR0.12
Enterprise Value477.58M
Avg Vol (3 Months)2.36M
Avg Vol (10 Days)1.42M

LXRX Technical Analysis Indicators

Lexicon Pharmaceuticals, Inc. (LXRX) technical indicators as of May 2, 2026: the SMA 20 is 11.4%, SMA 50 at 14.43%, and SMA 200 at 27.48%. The RSI 14 value is 57.73, suggesting its current momentum. These technical analysis signals help assess LXRX's price trends and potential future movements.

SMA 2011.4%
SMA 5014.43%
SMA 20027.48%
RSI 1457.73

LXRX Stock Performance Overview

Lexicon Pharmaceuticals, Inc. (LXRX) stock performance overview as of May 2, 2026: The 52-week high is $1.95 (currently -18.03% below), and the 52-week low is $0.514 (currently 428.91% above). Over the past year, LXRX's performance is 83.63%, compared to the S&P 500's 17.86% change.

52-Week High1.95
52-Week High Chg-18.03%
52-Week Low0.5137
52-Week Low Chg+428.91%
S&P 500 52-Week Chg17.86%

Lexicon Pharmaceuticals, Inc. (LXRX) Historical Stock Performance

According to market data, Lexicon Pharmaceuticals, Inc. (LXRX) stock's recent performance metrics show that over the last month, LXRX is 13.91%, with a Year-to-Date (YTD) performance of 13.91%. Over the past year, the stock has seen a 83.63% change. These figures summarize LXRX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High1.861.951.951.951.951.95
Low1.551.491.11.10.51371.1
Performance+11.02%+13.91%-7.75%+6.50%+83.63%+13.91%

Industry Analysis and Valuation

According to current financial data, LXRX stock's P/E (TTM) ratio is -11.66, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for LXRX, including P/S (13.74), P/B (5.46), and P/FCF (-10.08), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationLXRXSector MedianIndustry AvgS&P 500
P/E (TTM)-11.66-1.22-5.1232.59
P/S (TTM)13.743.69464.325.98
P/B (TTM)5.46-0.091.014.72
P/FCF (TTM)-10.08-191.12-462.1732.8

Frequently Asked Questions

How is LXRX price-to-earnings ratio currently?
LXRX has a current P/E ratio of -11.66
How are LXRX's price-to-sale and price-to-book ratios?
The LXRX stock has a trailing twelve month price-to sales (P/S) ratio of 13.74 while its price-to-book (P/B) value is 5.46.
Is Lexicon Pharmaceuticals, Inc.'s price-to-cashflow ratio high or low?
LXRX's price-to-free-cashflow (P/FCF) ratio is -10.08, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for LXRX?
Based on LXRX's recent bid, its distance from 20 days simple moving average is 11.4%. It is 14.43% apart from 50 days simple moving average, and it is 27.48% apart from 200 days simple moving average.
What is the 52-week price range for LXRX?
The 52-week high for LXRX is $1.95 which is -18.03% away from the current price level whereas the distance of that from the 52-week low of $0.51 stands at 428.91%.
An overview of LXRX's stock performance: how did it fare?
The performance of LXRX stock was not encouraging with most of its significant price indicators in green. Lexicon Pharmaceuticals, Inc.(NASDAQ: LXRX) shares have moved upward +3.87% or $0.06 in the latest trading session and have gained 13.91% year-to-date (YTD). The stock has gained nearly 83.63% over the past year. After moving -7.75% over the trailing 3-month period, the stock is 6.5% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 11.02% a week and 13.91% a month.
What is LXRX's 14-day relative strength index (RSI)?
The current 14-day RSI for LXRX stock is 57.73. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For LXRX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Lexicon Pharmaceuticals, Inc. (LXRX) has a 14-day ATR of 0.12.
What is LXRX's current enterprise value?
After closing at $1.55 with 423.68M of its shares outstanding, the current enterprise value of LXRX is roughly 477.58M.
Over the past year, how has the stock price of LXRX changed?
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is up 83.63% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 17.86%. LXRX stock price is also up 13.91% on its value in year-to-date trading.
What is the average trading volume for LXRX shares?
The number outstanding shares of LXRX is 423.68M, and of these 50.6% shares are freely available for trading. On average, LXRX stock has traded 1.42M shares per day for the past 10 days. A total of 1.16M shares changed hands during the last trading session with the average session volume of 2.44M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph